The IMH hosts the Cochrane Schizophrenia Group which supports researchers worldwide with the evaluation of the prevention, treatment and rehabilitation of people with psychotic illnesses.

The Cochrane Schizophrenia Group is part of the international Cochrane Collaboration, an independent, not-for-profit consortium dedicated to providing up-to-date, accurate information about the effects of health care.

The work of the Cochrane Schizophrenia Group editorial team is largely funded by the National Institute for Health Research (NIHR), with additional support from the University of Nottingham. Funding is also obtained from the delivery of the Nottingham Systematic Review Course, which contributes to the cost of providing administration support. The Group does not seek any funding from industry.

Further information from the Cochrane Schizophrenia Group website.